O-090 Foxo3 Is Activated in High-Risk Neuroblastoma and Contributes to Chemotherapy-Resistance and Angiogenesis

Archives of Disease in Childhood - United Kingdom
doi 10.1136/archdischild-2014-307384.158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Select BCL-2 Antagonism Restores Chemotherapy Sensitivity in High-Risk Neuroblastoma

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2020English

Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amplification of LAPTM4B and YWHAZ Contributes to Chemotherapy Resistance and Recurrence of Breast Cancer

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2010English

Treatment of Poor-Risk Neuroblastoma Patients With High-Dose Chemotherapy and Autologous Peripheral Stem Cell Rescue

Bone Marrow Transplantation
TransplantationHematology
1997English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Exosomal WNT-Induced Dedifferentiation of Colorectal Cancer Cells Contributes to Chemotherapy Resistance

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Efficacy and Risk Factors Associated to Resistance to Single-Agent Chemotherapy in Low-Risk Gestational Trophoblastic Neoplasia

Open Journal of Obstetrics and Gynecology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy